Case number 1:17-cv-01469
Takeda Pharmaceuticals U.S.A., Inc. v. Macleods Pharmaceuticals Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 2, 2018 | 13 | Patent/Trademark Report to Commissioner (2) |
| Feb 2, 2018 | 13 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297; US 7,619,004; US 7,601,758; US 7,820,681; US 7,915,269; US 7,964,647; US 7,981,938; US 8,093, 296; US 8,097,655; US 8,415,395; US 8,415, 396; US 8,440, 721; US 8,440,722. (Attachments: # (1) Order)(nms) |
| Feb 2, 2018 | 13 | Order (2) |
| Feb 2, 2018 | 12 | Order (2) Docket Text: SO ORDERED Granting [11] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 2/2/2018. (nms) |
| Feb 2, 2018 | 11 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal, by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) Modified on 2/2/2018 (nms). |
| Dec 19, 2017 | 10 | Order (2) Docket Text: SO ORDERED Granting [9] Stipulation and Order to Stay Action Pending Regulatory Review of Settlement. Signed by Judge Richard G. Andrews on 12/19/2017. (nms) |
| Dec 18, 2017 | 9 | Stipulation (2) Docket Text: STIPULATION and Proposed Order to Stay Action Pending Regulatory Review of Settlement by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) |
| Nov 1, 2017 | 8 | Notice (Other) (1) Docket Text: NOTICE of Firm Name Change by Takeda Pharmaceuticals U.S.A., Inc. (Bourke, Mary) |
| Oct 26, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] STIPULATION TO EXTEND TIME to Answer Complaint to December 18, 2017 (*Reset Answer Deadlines: Macleods Pharma USA, Inc. answer due 12/18/2017; Macleods Pharmaceuticals Ltd. answer due 12/18/2017). Signed by Judge Richard G. Andrews on 10/26/2017. (nms) |
| Oct 25, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (bkb) |
| Oct 20, 2017 | 7 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to December 18, 2017 - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) |
| Oct 19, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc.. Macleods Pharma USA, Inc. served on 10/18/2017, answer due 11/8/2017. (Bourke, Mary) |
| Oct 17, 2017 | 1 | Exhibit K (28) |
| Oct 17, 2017 | 1 | Exhibit L (36) |
| Oct 17, 2017 | 1 | Exhibit M (35) |
| Oct 17, 2017 | 1 | Exhibit N (19) |
| Oct 17, 2017 | 1 | Exhibit O (19) |
| Oct 17, 2017 | 1 | Exhibit P (31) |
| Oct 17, 2017 | 1 | Exhibit Q (31) |
| Oct 17, 2017 | 1 | Exhibit R (27) |
| Oct 17, 2017 | 1 | Exhibit S (26) |
| Oct 17, 2017 | 1 | Exhibit T (7) |
| Oct 17, 2017 | 1 | Exhibit U (4) |
| Oct 17, 2017 | 1 | Civil Cover Sheet (2) |
| Oct 17, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) |
| Oct 17, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/8/17. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 3/8/2020. (crb) |
| Oct 17, 2017 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): See Attachment. (crb) |
| Oct 17, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc. (crb) |
| Oct 17, 2017 | 1 | Exhibit J (26) |
| Oct 17, 2017 | 1 | Exhibit I (16) |
| Oct 17, 2017 | 1 | Exhibit H (16) |
| Oct 17, 2017 | 1 | Exhibit G (27) |
| Oct 17, 2017 | 1 | Exhibit F (29) |
| Oct 17, 2017 | 1 | Exhibit E (19) |
| Oct 17, 2017 | 1 | Exhibit D (16) |
| Oct 17, 2017 | 1 | Exhibit C (23) |
| Oct 17, 2017 | 1 | Exhibit B (16) |
| Oct 17, 2017 | 1 | Exhibit A (25) |
| Oct 17, 2017 | 1 | Complaint (39) |
| Oct 17, 2017 | 1 | Main Document (39) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2246602.) - filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Civil Cover Sheet)(crb) |
| Oct 17, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Macleods Pharma USA, Inc. on 10/17/2017; Macleods Pharmaceuticals Ltd. on 10/17/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb) |
| Oct 17, 2017 | 1 | Complaint* (1) |
